What information are urologists extracting from prostate needle biopsy reports and what do they need for clinical management of prostate cancer?

European Urology

Volumn 48, Issue 6, 2005, Pages 911-915

  Descazeaud, Aurélien ^a,b,c   Rubin, Mark A ^b,c   Allory, Yves ^a   Burchardt, Martin ^d   Salomon, Laurent ^a   Chopin, Dominique ^a   Abbou, Claude ^a   De La Taille, Alexandre ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Gleason score; Needle biopsy; Pathology report; Prostate cancer; Survey

Indexed keywords

ACINAR CELL; ADULT; AGED; CANCER GRADING; CANCER LOCALIZATION; CANCER PALLIATIVE THERAPY; CANCER SIZE; CELL PROLIFERATION; CLINICAL EXAMINATION; CONTROLLED STUDY; CONVALESCENCE; DEMOGRAPHY; HEALTH SURVEY; HUMAN; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; NEEDLE BIOPSY; PATHOLOGIST; PATIENT CARE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; QUESTIONNAIRE; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; TREATMENT PLANNING;

EID: 27844439578     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2005.07.011     Document Type: Article

References (17)

1. M.B. Amin, D. Grignon, D. Bostwick, V. Reuter, P. Troncoso, and A.G. Ayala Recommendations for the reporting of resected prostate carcinomas. Association of directors of anatomic and surgical pathology Am J Clin Pathol 105 1996 667 670
2. L. Boccon-Gibod, T.H. van der Kwast, R. Montironi, and A. Bono Handling and pathology reporting of prostate biopsies Eur Urol 46 2004 177 181
3. J.I. Epstein Atypical small acinar proliferation of the prostate gland Am J Surg Pathol 22 1998 1430 1431
4. W.A. Sakr, and D.J. Grignon Prostate. Practice parameters, pathologic staging, and handling radical prostatectomy specimens Urol Clin North Am 26 1999 453 463
5. T.H. van der Kwast, C. Lopes, C. Santonja, C.G. Pihl, I. Neetens, and P. Martikainen Guidelines for processing and reporting of prostatic needle biopsies J Clin Pathol 56 2003 336 340
6. M. Zhou, and J.I. Epstein The reporting of prostate cancer on needle biopsy: prognostic and therapeutic implications and the utility of diagnostic markers Pathology 35 2003 472 479
7. K.A. Iczkowski, GT. MacLennan, and D.G. Bostwick Atypical small acinar proliferation suspicious for malignancy in prostate needle biopsies: clinical significance in 33 cases Am J Surg Pathol 21 1997 1489 1495
8. K.A. Iczkowski, L. Cheng, J. Qian, J. Shanks, V. Gadaleanu, and D.G. Bostwick ASAP is a valid diagnosis. Atypical small acinar proliferation Hum Pathol 30 1999 1403 1404
9. KA. Iczkowski, and D.G. Bostwick Sampling, submission, and report format for multiple prostate biopsies: a 1999 survey Urology 55 2000 568 571
10. M.A. Rubin, T.A. Bismar, S. Curtis, and J.E. Montie Prostate needle biopsy reporting: how are the surgical members of the society of urologic oncology using pathology reports to guide treatment of prostate cancer patients? Am J Surg Pathol 28 2004 946 952
11. J.D. Kronz, W.H. Westra, and J.I. Epstein Mandatory second opinion surgical pathology at a large referral hospital Cancer 86 1999 2426 2435
12. M.W. Kattan, J.A. Eastham, A.M. Stapleton, TM. Wheeler, and P.T. Scardino A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer J Natl Cancer Inst 90 1998 766 771
13. M.W. Kattan, M.J. Zelefsky, P.A. Kupelian, P.T. Scardino, Z. Fuks, and S.A. Leibel Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer J Clin Oncol 18 2000 3352 3359
14. M.W. Kattan, L. Potters, J.C. Blasko, D.C. Beyer, P. Fearn, and W. Cavanagh Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer Urology 58 2001 393 399
15. A.W. Partin, M.W. Kattan, E.N. Subong, P.C. Walsh, K.J. Wojno, and J.E. Oesterling Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update JAMA 277 1997 1445 1451
16. W.A. Sakr Prostatic intraepithelial neoplasia: A marker for high-risk groups and a potential target for chemoprevention Eur Urol 35 1999 474 478
17. M. Che, W. Sakr, and D. Grignon Pathologic features the urologist should expect on a prostate biopsy Urol Oncol 21 2003 153 161